Correlates of 5-year decline in 6-min walk distance in the COPDGene cohort.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 41980814.
- Also identified by DOI 10.1136/thorax-2025-224183.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Change in 6-min walk distance (6MWD) over time serves as a measure of change in functional exercise performance. We analysed a large cohort of current or former tobacco smokers over a 5-year period to identify correlates of 6MWD decline. A total of 4734 participants with normal spirometry or spirometric evidence of chronic obstructive pulmonary disease (COPD) who completed a 5-year follow-up in the COPDGene study were included. Baseline and 5-year assessments included 6MWD, spirometry, St. George's Respiratory Questionnaire (SGRQ), gender, race and CT measures of emphysema, gas trapping and airway wall thickness. 6MWD decline correlates relative to baseline and 5-year changes were examined using univariate and multivariate linear regression. At baseline, 2573 had normal spirometry; 487 were classified as GOLD1, 1044 as GOLD2, 514 as GOLD3 and 116 as GOLD4. Average 5-year decline in 6MWD was 35.6±101.7 (SD) metres (p<0.001). COPD participants experienced greater 6MWD decline (44.1±101.9 m, p<0.001) compared with those with normal spirometry (28.5±101.0 m, p<0.001). Only baseline 6MWD and study site accounted for appreciable fractions of 6MWD decline variance (R<sup>2</sup>=12.1% and 9.1%, respectively). 5 year change in variables assessed (including FEV<sub>1</sub> and SGRQ) explained only small fractions of 6MWD decline variance (each R<sup>2</sup>≤5%). 6MWD declined significantly, but with high variability; spirometry, CT, health status, demographic and anthropometric measures accounted for only small portions of this variance. Our findings suggest that a meaningful decline in 6MWD observed over 5 years in COPD patients is in large part related to factors other than decline in pulmonary structure or function.